Literature DB >> 12901596

Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.

Katri Jalava1, Francis O Eko, Eva Riedmann, Werner Lubitz.   

Abstract

The application of new strategies to develop effective vaccines is essential in modern medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope-bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origin can be presented to the immune system simultaneously. In addition, the extended bacterial ghost system represents a platform technology for specific targeting of DNA-encoded antigens to primary antigen-presenting cells. The potency, safety and relatively low production cost of bacterial ghosts offer a significant technical advantage, especially when used as combination vaccines.

Mesh:

Substances:

Year:  2003        PMID: 12901596     DOI: 10.1586/14760584.2.1.45

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  22 in total

1.  Lytic Action of the Truncated yncE Gene in Escherichia coli.

Authors:  Jianhua Li; Kun Xiong; Lingyun Zou; Zhijin Chen; Yiran Wang; Xiaomei Hu; Xiancai Rao; Yanguang Cong
Journal:  Curr Microbiol       Date:  2015-12-21       Impact factor: 2.188

2.  Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.

Authors:  Ulrike Beate Mayr; Christoph Haller; Wolfgang Haidinger; Alena Atrasheuskaya; Eugenij Bukin; Werner Lubitz; Georgy Ignatyev
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  A novel inducible expression system for the functional study of toxic gene in bacteria.

Authors:  Jihua Guo; Rong Jia
Journal:  World J Microbiol Biotechnol       Date:  2013-12-11       Impact factor: 3.312

Review 4.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

5.  Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.

Authors:  Mingming Hu; Yanhe Zhang; Fang Xie; Gang Li; Jianjun Li; Wei Si; Siguo Liu; Shouping Hu; Zhuo Zhang; Nan Shen; Chunlai Wang
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

6.  Protective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis.

Authors:  Jin Hur; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

7.  Novel expression system for combined vaccine production in Edwardsiella tarda ghost and cadaver cells.

Authors:  Seung Hyuk Choi; Yoon Kwon Nam; Ki Hong Kim
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

Review 8.  Linking autoantigen properties to mechanisms of immunity.

Authors:  J Daniel Griffin; Jimmy Y Song; Joshua O Sestak; Brandon J DeKosky; Cory J Berkland
Journal:  Adv Drug Deliv Rev       Date:  2020-04-20       Impact factor: 15.470

Review 9.  Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?

Authors:  Fatemeh Farjadian; Mohsen Moghoofei; Soroush Mirkiani; Amir Ghasemi; Navid Rabiee; Shima Hadifar; Ali Beyzavi; Mahdi Karimi; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

Review 10.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.